Have a feature idea you'd love to see implemented?
Let us know!
KOD Kodiak Sciences Inc
Price (delayed)
$3.56
Market cap
$187.31M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.76
Enterprise value
$37.66M
Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new
Highlights
Kodiak Sciences's quick ratio has soared by 105% YoY and by 4.8% from the previous quarter
The EPS has grown by 34% YoY and by 15% from the previous quarter
The equity has declined by 37% year-on-year and by 11% since the previous quarter
Key stats
What are the main financial stats of KOD
Market
Valuations
Earnings
Shares outstanding
52.61M
Market cap
$187.31M
Enterprise value
$37.66M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.87
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$197.67M
EBITDA
-$170.71M
Free cash flow
-$158.88M
Per share
Balance sheet
Liquidity
EPS
-$3.76
Free cash flow per share
-$3.02
Book value per share
$4.08
Revenue per share
$0
TBVPS
$7.64
Total assets
$401.58M
Total liabilities
$187.07M
Debt
$75.76M
Equity
$214.51M
Working capital
$203.43M
Debt to equity
0.35
Current ratio
10.59
Quick ratio
10.63
Net debt/EBITDA
0.88
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-42.4%
Return on equity
-77.2%
Return on invested capital
-87.6%
Return on capital employed
-52%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOD stock price
How has the Kodiak Sciences stock price performed over time
Intraday
-2.47%
1 week
18.67%
1 month
41.83%
1 year
128.21%
YTD
17.11%
QTD
36.4%
Financial performance
How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$211.91M
Net income
-$197.68M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has increased by 34% YoY and by 15% QoQ
The operating income has grown by 32% YoY and by 15% from the previous quarter
Growth
What is Kodiak Sciences's growth rate over time
Valuation
What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
0.87
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 34% YoY and by 15% from the previous quarter
The stock's P/B is 77% below its 5-year quarterly average of 3.9 but 27% above its last 4 quarters average of 0.7
The equity has declined by 37% year-on-year and by 11% since the previous quarter
Efficiency
How efficient is Kodiak Sciences business performance
KOD's ROIC is down by 19% year-on-year but it is up by 16% since the previous quarter
The ROA has grown by 7% YoY and by 7% from the previous quarter
KOD's return on equity is down by 6% year-on-year but it is up by 4.8% since the previous quarter
Dividends
What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOD.
Financial health
How did Kodiak Sciences financials performed over time
The total assets is 115% greater than the total liabilities
Kodiak Sciences's quick ratio has soared by 105% YoY and by 4.8% from the previous quarter
KOD's current ratio has surged by 103% year-on-year and by 4.6% since the previous quarter
KOD's debt is 65% lower than its equity
KOD's debt to equity is up by 40% YoY and by 9% from the previous quarter
The equity has declined by 37% year-on-year and by 11% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.